William Alberto Méndez Hurtado
Research Subjects
Research Interests
William Alberto Méndez Hurtado has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Alejandra Hernandez Salas
Universidad Colegio Mayor de Cundinamarca, Facultad de Ciencias de la Salud, Bogotá, Cundinamarca, Colombia
1 shared publication - Ana María Páez Bonelo
Universidad Colegio Mayor de Cundinamarca, Facultad de Ciencias de la Salud, Bogotá, Cundinamarca, Colombia
1 shared publication - Johanna Marcela Moscoso Gama
Universidad Colegio Mayor de Cundinamarca
1 shared publication
Latest Publications
- Open Access
- 13 December 2023
- Published by Universidad Nacional Autonoma de Mexico in Veterinaria México OA
- Vol. 10
Revisión del hemangiosarcoma canino: una neoplasia agresiva y mortal
Hemangiosarcoma (HSA) is an aggressive and malignant tumor that occurs in endothelial cells and invades blood vessels. It typically occurs in canines aged 6 to 13 years, with certain breeds, including German Shepherds, Golden Retrievers, Labradors, and Boxers, are predisposed. It can occur in any part of the animal’s body and can be found in the heart, liver, skin, and bones, although its most common location is in the spleen. Its importance lies in the fact that few canines can be diagnosed before the tumor ruptures and causes severe abdominal bleeding, leading to anemia, weakness, and collapse. This study provides an updated review of various methods for diagnosis and treatment, placing emphasis on ontogeny, genetics, mutations, signaling pathways, and significant markers like CD133, CD117, CD45, and CD34. The goal is to facilitate a timely diagnosis through molecular biology and effective treatment, thereby enhancing the survival time of the canine with HSA. Likewise, the aim is to broaden the outlook for professionals at the time of early detection of HSA, to reduce the damage caused to the canine, which is extremely traumatic and painful during this pathology.
- 13 December 2023
- Published by Universidad Nacional Autonoma de Mexico in Veterinaria México OA
- Vol. 10
Open AccessRevisión del hemangiosarcoma canino: una neoplasia agresiva y mortal
Hemangiosarcoma (HSA) is an aggressive and malignant tumor that occurs in endothelial cells and invades blood vessels. It typically occurs in canines aged 6 to 13 years, with certain breeds, including German Shepherds, Golden Retrievers, Labradors, and Boxers, are predisposed. It can occur in any part of the animal’s body and can be found in the heart, liver, skin, and bones, although its most common location is in the spleen. Its importance lies in the fact that few canines can be diagnosed before the tumor ruptures and causes severe abdominal bleeding, leading to anemia, weakness, and collapse. This study provides an updated review of various methods for diagnosis and treatment, placing emphasis on ontogeny, genetics, mutations, signaling pathways, and significant markers like CD133, CD117, CD45, and CD34. The goal is to facilitate a timely diagnosis through molecular biology and effective treatment, thereby enhancing the survival time of the canine with HSA. Likewise, the aim is to broaden the outlook for professionals at the time of early detection of HSA, to reduce the damage caused to the canine, which is extremely traumatic and painful during this pathology.